Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C.

The therapeutic use of interferon (IFN) is known to cause depression that frequently interrupts treatment. To identify genetic variants associated with IFN-induced depression, we conducted a genome-wide association study (GWAS) of 224 Japanese chronic hepatitis C patients receiving IFN-based therapy...

Full description

Bibliographic Details
Main Authors: Kayoko Matsunami, Nao Nishida, Naoko Kaneko, Kazuho Ikeo, Licht Toyo-Oka, Hiroshi Takeuchi, Kentaro Matsuura, Akihiro Tamori, Hideyuki Nomura, Hitoshi Yoshiji, Masatoshi Imamura, Naohiko Masaki, Tatsuro Hayakawa, Tatsuya Ide, Noritomo Shimada, Fusao Ikeda, Keisuke Hino, Shuhei Nishiguchi, Chiaki Okuse, Shunsuke Nojiri, Kazunobu Sawamoto, Katsushi Tokunaga, Takashi Joh, Yasuhito Tanaka
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5056723?pdf=render
id doaj-90ba711f4a6141fbb80ebd775f16ddd1
record_format Article
spelling doaj-90ba711f4a6141fbb80ebd775f16ddd12020-11-25T02:47:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-011110e016441810.1371/journal.pone.0164418Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C.Kayoko MatsunamiNao NishidaNaoko KanekoKazuho IkeoLicht Toyo-OkaHiroshi TakeuchiKentaro MatsuuraAkihiro TamoriHideyuki NomuraHitoshi YoshijiMasatoshi ImamuraNaohiko MasakiTatsuro HayakawaTatsuya IdeNoritomo ShimadaFusao IkedaKeisuke HinoShuhei NishiguchiChiaki OkuseShunsuke NojiriKazunobu SawamotoKatsushi TokunagaTakashi JohYasuhito TanakaThe therapeutic use of interferon (IFN) is known to cause depression that frequently interrupts treatment. To identify genetic variants associated with IFN-induced depression, we conducted a genome-wide association study (GWAS) of 224 Japanese chronic hepatitis C patients receiving IFN-based therapy in a multicenter prospective study and stratified them into two groups according to the Beck Depression Inventory, Second Edition (BDI-II) score. In the GWAS stage, we selected 42 candidate single nucleotide polymorphisms (SNPs) to perform replication analysis in an independent set of 160 subjects. The SNP rs1863918 in strong linkage disequilibrium with SNPs located around the Zinc finger 354C (ZNF354C) gene on chromosome 5 showed a significant association when the results of GWAS and replication were combined (odds ratio = 2.55, P = 7.89×10-8 in the allele frequency model), suggesting that the rs1863918 T allele was associated with IFN-induced depression. Furthermore, logistic regression analysis showed that rs1863918 T allele, a history of depression, and younger age were independent predictive factors for IFN-induced depression. Interestingly, western blotting and immunofluorescence showed that ZNF354C was highly expressed in the hippocampus in mice, a region implicated in the pathology of psychiatric symptoms. In conclusion, we identified rs1863918 as significantly associated with IFN-induced depression, and revealed that the candidate gene ZNF354C is highly expressed in the hippocampus of mice. Our data might be useful for elucidating the pathogenic mechanisms of depression induced by drugs including IFN.http://europepmc.org/articles/PMC5056723?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Kayoko Matsunami
Nao Nishida
Naoko Kaneko
Kazuho Ikeo
Licht Toyo-Oka
Hiroshi Takeuchi
Kentaro Matsuura
Akihiro Tamori
Hideyuki Nomura
Hitoshi Yoshiji
Masatoshi Imamura
Naohiko Masaki
Tatsuro Hayakawa
Tatsuya Ide
Noritomo Shimada
Fusao Ikeda
Keisuke Hino
Shuhei Nishiguchi
Chiaki Okuse
Shunsuke Nojiri
Kazunobu Sawamoto
Katsushi Tokunaga
Takashi Joh
Yasuhito Tanaka
spellingShingle Kayoko Matsunami
Nao Nishida
Naoko Kaneko
Kazuho Ikeo
Licht Toyo-Oka
Hiroshi Takeuchi
Kentaro Matsuura
Akihiro Tamori
Hideyuki Nomura
Hitoshi Yoshiji
Masatoshi Imamura
Naohiko Masaki
Tatsuro Hayakawa
Tatsuya Ide
Noritomo Shimada
Fusao Ikeda
Keisuke Hino
Shuhei Nishiguchi
Chiaki Okuse
Shunsuke Nojiri
Kazunobu Sawamoto
Katsushi Tokunaga
Takashi Joh
Yasuhito Tanaka
Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C.
PLoS ONE
author_facet Kayoko Matsunami
Nao Nishida
Naoko Kaneko
Kazuho Ikeo
Licht Toyo-Oka
Hiroshi Takeuchi
Kentaro Matsuura
Akihiro Tamori
Hideyuki Nomura
Hitoshi Yoshiji
Masatoshi Imamura
Naohiko Masaki
Tatsuro Hayakawa
Tatsuya Ide
Noritomo Shimada
Fusao Ikeda
Keisuke Hino
Shuhei Nishiguchi
Chiaki Okuse
Shunsuke Nojiri
Kazunobu Sawamoto
Katsushi Tokunaga
Takashi Joh
Yasuhito Tanaka
author_sort Kayoko Matsunami
title Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C.
title_short Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C.
title_full Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C.
title_fullStr Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C.
title_full_unstemmed Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C.
title_sort genome-wide association study identifies znf354c variants associated with depression from interferon-based therapy for chronic hepatitis c.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2016-01-01
description The therapeutic use of interferon (IFN) is known to cause depression that frequently interrupts treatment. To identify genetic variants associated with IFN-induced depression, we conducted a genome-wide association study (GWAS) of 224 Japanese chronic hepatitis C patients receiving IFN-based therapy in a multicenter prospective study and stratified them into two groups according to the Beck Depression Inventory, Second Edition (BDI-II) score. In the GWAS stage, we selected 42 candidate single nucleotide polymorphisms (SNPs) to perform replication analysis in an independent set of 160 subjects. The SNP rs1863918 in strong linkage disequilibrium with SNPs located around the Zinc finger 354C (ZNF354C) gene on chromosome 5 showed a significant association when the results of GWAS and replication were combined (odds ratio = 2.55, P = 7.89×10-8 in the allele frequency model), suggesting that the rs1863918 T allele was associated with IFN-induced depression. Furthermore, logistic regression analysis showed that rs1863918 T allele, a history of depression, and younger age were independent predictive factors for IFN-induced depression. Interestingly, western blotting and immunofluorescence showed that ZNF354C was highly expressed in the hippocampus in mice, a region implicated in the pathology of psychiatric symptoms. In conclusion, we identified rs1863918 as significantly associated with IFN-induced depression, and revealed that the candidate gene ZNF354C is highly expressed in the hippocampus of mice. Our data might be useful for elucidating the pathogenic mechanisms of depression induced by drugs including IFN.
url http://europepmc.org/articles/PMC5056723?pdf=render
work_keys_str_mv AT kayokomatsunami genomewideassociationstudyidentifiesznf354cvariantsassociatedwithdepressionfrominterferonbasedtherapyforchronichepatitisc
AT naonishida genomewideassociationstudyidentifiesznf354cvariantsassociatedwithdepressionfrominterferonbasedtherapyforchronichepatitisc
AT naokokaneko genomewideassociationstudyidentifiesznf354cvariantsassociatedwithdepressionfrominterferonbasedtherapyforchronichepatitisc
AT kazuhoikeo genomewideassociationstudyidentifiesznf354cvariantsassociatedwithdepressionfrominterferonbasedtherapyforchronichepatitisc
AT lichttoyooka genomewideassociationstudyidentifiesznf354cvariantsassociatedwithdepressionfrominterferonbasedtherapyforchronichepatitisc
AT hiroshitakeuchi genomewideassociationstudyidentifiesznf354cvariantsassociatedwithdepressionfrominterferonbasedtherapyforchronichepatitisc
AT kentaromatsuura genomewideassociationstudyidentifiesznf354cvariantsassociatedwithdepressionfrominterferonbasedtherapyforchronichepatitisc
AT akihirotamori genomewideassociationstudyidentifiesznf354cvariantsassociatedwithdepressionfrominterferonbasedtherapyforchronichepatitisc
AT hideyukinomura genomewideassociationstudyidentifiesznf354cvariantsassociatedwithdepressionfrominterferonbasedtherapyforchronichepatitisc
AT hitoshiyoshiji genomewideassociationstudyidentifiesznf354cvariantsassociatedwithdepressionfrominterferonbasedtherapyforchronichepatitisc
AT masatoshiimamura genomewideassociationstudyidentifiesznf354cvariantsassociatedwithdepressionfrominterferonbasedtherapyforchronichepatitisc
AT naohikomasaki genomewideassociationstudyidentifiesznf354cvariantsassociatedwithdepressionfrominterferonbasedtherapyforchronichepatitisc
AT tatsurohayakawa genomewideassociationstudyidentifiesznf354cvariantsassociatedwithdepressionfrominterferonbasedtherapyforchronichepatitisc
AT tatsuyaide genomewideassociationstudyidentifiesznf354cvariantsassociatedwithdepressionfrominterferonbasedtherapyforchronichepatitisc
AT noritomoshimada genomewideassociationstudyidentifiesznf354cvariantsassociatedwithdepressionfrominterferonbasedtherapyforchronichepatitisc
AT fusaoikeda genomewideassociationstudyidentifiesznf354cvariantsassociatedwithdepressionfrominterferonbasedtherapyforchronichepatitisc
AT keisukehino genomewideassociationstudyidentifiesznf354cvariantsassociatedwithdepressionfrominterferonbasedtherapyforchronichepatitisc
AT shuheinishiguchi genomewideassociationstudyidentifiesznf354cvariantsassociatedwithdepressionfrominterferonbasedtherapyforchronichepatitisc
AT chiakiokuse genomewideassociationstudyidentifiesznf354cvariantsassociatedwithdepressionfrominterferonbasedtherapyforchronichepatitisc
AT shunsukenojiri genomewideassociationstudyidentifiesznf354cvariantsassociatedwithdepressionfrominterferonbasedtherapyforchronichepatitisc
AT kazunobusawamoto genomewideassociationstudyidentifiesznf354cvariantsassociatedwithdepressionfrominterferonbasedtherapyforchronichepatitisc
AT katsushitokunaga genomewideassociationstudyidentifiesznf354cvariantsassociatedwithdepressionfrominterferonbasedtherapyforchronichepatitisc
AT takashijoh genomewideassociationstudyidentifiesznf354cvariantsassociatedwithdepressionfrominterferonbasedtherapyforchronichepatitisc
AT yasuhitotanaka genomewideassociationstudyidentifiesznf354cvariantsassociatedwithdepressionfrominterferonbasedtherapyforchronichepatitisc
_version_ 1724754763425251328